160 related articles for article (PubMed ID: 26658102)
1. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
[TBL] [Abstract][Full Text] [Related]
2. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.
Kato Y; Ochiai K; Kawakami S; Nakao N; Azakami D; Bonkobara M; Michishita M; Morimatsu M; Watanabe M; Omi T
BMC Vet Res; 2017 Jun; 13(1):170. PubMed ID: 28599655
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor REIC/Dkk-3 and its interacting protein SGTA inhibit glucocorticoid receptor to nuclear transport.
Iwata T; Sadahira T; Ochiai K; Ueki H; Sasaki T; Haung P; Araki M; Watanabe T; Nasu Y; Watanabe M
Exp Ther Med; 2020 Aug; 20(2):1739-1745. PubMed ID: 32765682
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.
Ochiai K; Watanabe M; Ueki H; Huang P; Fujii Y; Nasu Y; Noguchi H; Hirata T; Sakaguchi M; Huh NH; Kashiwakura Y; Kaku H; Kumon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):391-5. PubMed ID: 21835165
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
[TBL] [Abstract][Full Text] [Related]
7. Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client.
Trotta AP; Need EF; Butler LM; Selth LA; O'Loughlin MA; Coetzee GA; Tilley WD; Buchanan G
J Mol Endocrinol; 2012 Oct; 49(2):57-68. PubMed ID: 22693264
[TBL] [Abstract][Full Text] [Related]
8. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
[TBL] [Abstract][Full Text] [Related]
9. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer.
Nozaki I; Tsuji T; Iijima O; Ohmura Y; Andou A; Miyazaki M; Shimizu N; Namba M
Int J Oncol; 2001 Jul; 19(1):117-21. PubMed ID: 11408931
[TBL] [Abstract][Full Text] [Related]
12. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
[TBL] [Abstract][Full Text] [Related]
14. Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.
Butler MS; Yang X; Ricciardelli C; Liang X; Norman RJ; Tilley WD; Hickey TE
Fertil Steril; 2013 Jun; 99(7):2076-83.e1. PubMed ID: 23433514
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
[TBL] [Abstract][Full Text] [Related]
16. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
[TBL] [Abstract][Full Text] [Related]
17. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
[TBL] [Abstract][Full Text] [Related]
19. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas.
Tsuji T; Nozaki I; Miyazaki M; Sakaguchi M; Pu H; Hamazaki Y; Iijima O; Namba M
Biochem Biophys Res Commun; 2001 Nov; 289(1):257-63. PubMed ID: 11708809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
